182 related articles for article (PubMed ID: 16227635)
21. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
Tokugawa T; Sugihara H; Tani T; Hattori T
Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.
Salam I; Hussain S; Mir MM; Dar NA; Abdullah S; Siddiqi MA; Lone RA; Zargar SA; Sharma S; Hedau S; Basir SF; Bharti AC; Das BC
Mol Cell Biochem; 2009 Dec; 332(1-2):51-8. PubMed ID: 19513816
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
26. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
29. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
[TBL] [Abstract][Full Text] [Related]
30. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
[TBL] [Abstract][Full Text] [Related]
35. DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.
Huang J; Wang G; Tang J; Zhuang W; Wang LP; Liou YL; Liu YZ; Zhou HH; Zhu YS
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28241446
[TBL] [Abstract][Full Text] [Related]
36. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
37. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
[TBL] [Abstract][Full Text] [Related]
38. p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India.
Das M; Saikia BJ; Sharma SK; Sekhon GS; Mahanta J; Phukan RK
Tumour Biol; 2015 Mar; 36(3):1627-42. PubMed ID: 25361631
[TBL] [Abstract][Full Text] [Related]
39. p14ARF repression induced by promoter methylation associated with metastasis in esophageal squamous cell carcinoma.
Ling Y; Zhang C; Shen R; Xu Y; Zhu C; Lu M; Liu Y; Zhang C
Dis Esophagus; 2014; 27(2):182-7. PubMed ID: 22973996
[TBL] [Abstract][Full Text] [Related]
40. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]